| Aftesha Cooper, | |
|
6901 Medical Pkwy, Waco, TX 76712-7910 | |
| (254) 751-4142 | |
| Not Available |
| Full Name | Aftesha Cooper |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 6901 Medical Pkwy, Waco, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043698194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP127758 (Texas) | Primary |
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
President Donald Trump has collided with a wave of public disagreement by moving to strip the Affordable Care Act of provisions intended to keep insurance prices stable.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
President Obama urged Congress to enact into law tough financial rules requiring them to offset any new spending or taxes, but was clear that where health care is concerned, lawmakers should overlook those rules, Bloomberg reports.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 3 days ago
| Entity Name | Texacare Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376090472 PECOS PAC ID: 0941580120 Enrollment ID: O20161205001383 |
News Archive
President Donald Trump has collided with a wave of public disagreement by moving to strip the Affordable Care Act of provisions intended to keep insurance prices stable.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
President Obama urged Congress to enact into law tough financial rules requiring them to offset any new spending or taxes, but was clear that where health care is concerned, lawmakers should overlook those rules, Bloomberg reports.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 3 days ago
| Entity Name | Meridian Health Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215533807 PECOS PAC ID: 5597170878 Enrollment ID: O20210218002098 |
News Archive
President Donald Trump has collided with a wave of public disagreement by moving to strip the Affordable Care Act of provisions intended to keep insurance prices stable.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
President Obama urged Congress to enact into law tough financial rules requiring them to offset any new spending or taxes, but was clear that where health care is concerned, lawmakers should overlook those rules, Bloomberg reports.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aftesha Cooper, 6901 Medical Pkwy, Waco, TX 76712-7910 Ph: () - | Aftesha Cooper, 6901 Medical Pkwy, Waco, TX 76712-7910 Ph: (254) 751-4142 |
News Archive
President Donald Trump has collided with a wave of public disagreement by moving to strip the Affordable Care Act of provisions intended to keep insurance prices stable.
Hundreds of thousands of Medicare beneficiaries who have been denied coverage for nursing home stays because their time in the hospital was changed from "inpatient" to "observation care" can now appeal to Medicare for reimbursement, a federal judge in Hartford, Connecticut, ruled last week.
President Obama urged Congress to enact into law tough financial rules requiring them to offset any new spending or taxes, but was clear that where health care is concerned, lawmakers should overlook those rules, Bloomberg reports.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 3 days ago
Leslie P Smith, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1800 Gurley Lane, Waco, TX 76706 Phone: 254-313-6000 Fax: 254-313-4531 | |
Karen Church, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 611 W Hwy 6 Ste 101, Waco, TX 76710 Phone: 254-755-4582 | |
Emily Heeringa, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Jared Blake Griffin, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2900 | |
Dallas Leigh Upchurch, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 345 Owen Ln Ste 144a, Waco, TX 76710 Phone: 254-300-4072 Fax: 254-362-2064 | |
Andrea Denise Nemec, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-5300 | |
Kandace Marie Bullajian, RN, MSN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7300 Bosque Blvd, Waco, TX 76710 Phone: 254-202-2600 Fax: 254-202-2650 |